Trevi Therapeutics

Sandy Hook, United States

Trevi Therapeutics is a clinical-stage biopharmaceutical company that develops drugs for treating uremic pruritus.

Apr 2026

Post-IPO Equity

Biotechnology Health Care Pharmaceutical

Top Investors

Vivo CapitalAdage Capital ManagementNew Enterprise AssociatesOmega FundsFrazier Life Sciences

Founder Contacts

19,000+ verified contacts

Get Instant Access

Emails, phones & LinkedIn profiles

Frequently Asked Questions about Trevi Therapeutics

Who are Trevi Therapeutics's investors?

Trevi Therapeutics's investors include Vivo Capital, Adage Capital Management, New Enterprise Associates, Omega Funds, Frazier Life Sciences.

Where is Trevi Therapeutics headquartered?

Trevi Therapeutics is headquartered in Sandy Hook, United States.

What does Trevi Therapeutics do?

Trevi Therapeutics is a clinical-stage biopharmaceutical company that develops drugs for treating uremic pruritus.

What stage is Trevi Therapeutics at?

Trevi Therapeutics is at the Post-IPO Equity stage.

Cite this page

Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated April 16, 2026.

MLA

"Trevi Therapeutics — Funding & Investors." VCBacked, April 16, 2026, https://www.vcbacked.co/company/trevi-therapeutics. Accessed June 3, 2026.

APA

VCBacked. (2026). Trevi Therapeutics — Funding & Investors. Retrieved June 3, 2026, from https://www.vcbacked.co/company/trevi-therapeutics

Wikipedia (cite web)

{{cite web |title=Trevi Therapeutics — Funding & Investors |url=https://www.vcbacked.co/company/trevi-therapeutics |website=VCBacked |access-date=June 3, 2026}}

Profile data sourced and verified per the VCBacked methodology. Last funding round dated April 16, 2026.

Similar Companies in Biotechnology